The purpose of this study to find out if enzalutamide, alone or combined with mifepristone, is effective in treating a specific type of breast cancer in comparison with standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin. The specific type of breast cancer include Triple-negative or ER/PgR-low and Androgen receptor positive breast cancer.
The study involves study drug infusions or dosing, physical exams, Electrocardiogram (ECG) (if needed), CT or MRI scans, Brain MRI or CT (If needed), routine and research blood tests, collection of tumor tissue, biopsy (if needed), questionnaires.
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Yara Abdou
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
24-0602